Matches in Wikidata for { <http://www.wikidata.org/entity/Q66397188> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q66397188 description "clinical trial" @default.
- Q66397188 description "ensayu clínicu" @default.
- Q66397188 description "klinisch onderzoek" @default.
- Q66397188 description "клінічне випробування" @default.
- Q66397188 description "կլինիկական փորձարկում" @default.
- Q66397188 name "A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes" @default.
- Q66397188 name "A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes" @default.
- Q66397188 type Item @default.
- Q66397188 label "A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes" @default.
- Q66397188 label "A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes" @default.
- Q66397188 prefLabel "A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes" @default.
- Q66397188 prefLabel "A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes" @default.
- Q66397188 P1050 Q66397188-1646B8E6-E733-49E7-842C-EC5A8A0E32F9 @default.
- Q66397188 P1050 Q66397188-2C0D98D7-F6D3-462F-A744-387F00C46D88 @default.
- Q66397188 P1132 Q66397188-78284743-065A-461D-A21B-59CB15A0805A @default.
- Q66397188 P1476 Q66397188-72671FED-6968-4B46-BD54-65B59321A378 @default.
- Q66397188 P17 Q66397188-606625BD-540E-4123-BC0B-C2E3FD90C982 @default.
- Q66397188 P17 Q66397188-8008D7BF-0910-4225-BBAE-3D22E56696B9 @default.
- Q66397188 P17 Q66397188-988DCCF9-3488-4AFC-8238-8565E2AA9AA4 @default.
- Q66397188 P17 Q66397188-BDDB36DC-90A0-4ED9-9730-238ED3320F61 @default.
- Q66397188 P17 Q66397188-E4254C85-A28E-4AAB-9619-77BDDD4D03CC @default.
- Q66397188 P17 Q66397188-E7199F56-B6DD-49F8-BFC9-A54D6C8BB615 @default.
- Q66397188 P17 Q66397188-F734D1F6-FE39-4855-81B5-56D3E36BB25C @default.
- Q66397188 P2899 Q66397188-5540A83F-6FFE-4DC0-A091-147941CEF83B @default.
- Q66397188 P3098 Q66397188-4E773944-CF7E-4B4D-967E-40D603984256 @default.
- Q66397188 P31 Q66397188-B203961A-A174-4E03-97CA-DB42CDB70B8F @default.
- Q66397188 P580 Q66397188-7E1BB8EE-D0C2-4D19-BC04-1327880F552A @default.
- Q66397188 P582 Q66397188-AD593C81-846F-427C-A24A-8D1510CC5AF8 @default.
- Q66397188 P6099 Q66397188-DE09C53A-F055-4F58-A11C-26418F2B29E1 @default.
- Q66397188 P8363 Q66397188-90B6918D-D13C-4D0D-8DC2-5F33DDC0DF6A @default.
- Q66397188 P921 Q66397188-FF5AF952-F708-46C7-B1CD-051D3FFA74F2 @default.
- Q66397188 P1050 Q179630 @default.
- Q66397188 P1050 Q29496 @default.
- Q66397188 P1132 "+70" @default.
- Q66397188 P1476 "A Phase 1, Open-label, Dose-Finding Study of CC-90009, a Novel Cereblon E3 Ligase Modulating Drug, in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes" @default.
- Q66397188 P17 Q142 @default.
- Q66397188 P17 Q145 @default.
- Q66397188 P17 Q16 @default.
- Q66397188 P17 Q20 @default.
- Q66397188 P17 Q29 @default.
- Q66397188 P17 Q30 @default.
- Q66397188 P17 Q38 @default.
- Q66397188 P2899 "+18" @default.
- Q66397188 P3098 "NCT02848001" @default.
- Q66397188 P31 Q30612 @default.
- Q66397188 P580 "2016-11-14T00:00:00Z" @default.
- Q66397188 P582 "2021-03-12T00:00:00Z" @default.
- Q66397188 P6099 Q5452194 @default.
- Q66397188 P8363 Q78089383 @default.
- Q66397188 P921 Q954625 @default.